Subscribe to our company announcement email listProduct Milestones
-
PeriCoach Patent Granted in Canada13 July 2022
Analytica announces the granting of patent protection in Canada for the Motion sensing capability in pelvic floor exercise devices.
-
PeriCoach ISO 13485 Certification26 May 2022
Analytica granted ISO13485:2016 certification for the design, development, production, sales and distribution of the PeriCoach, allowing global sales of in-house manufactured product.
-
PeriCoach Patents Granted in Europe and India18 May 2022
Analytica announces the granting of patent protection in Europe and India for the arrangement of force sensors in pelvic floor exercise devices.
-
US Patent Grant for PeriCoach11 November 2021
Analytica announces the granting of patent protection in the USA for the arrangement of force sensors in pelvic floor exercise devices.
-
Manufacturing Strategy Update and Queensland Government Support06 September 2021
Analytica wishes to update shareholders on its strategy to manufacture and supply its PeriCoach product to meet prospective demand, and financial support offered by the Queensland Government under its Advance Queensland Industry Attraction Fund (AQIAF).
-
US Patent Grant for PeriCoach30 April 2021
Analytica announces the granting of patent protection in the USA for motion sensing in pelvic floor exercise devices.
-
Expansion of Enhanced Infusion System into Middle East20 April 2021
Analytica has entered into an agreement with an Egyptian entity to distribute and market the EIS in Egypt, Bahrain, Iran, Iraq, Jordan, Kuwait, Lebanon, Saudi Arabia and UAE.
-
Expansion into China with PeriCoach JV30 March 2021
Analytica has entered into a joint venture agreement to manufacture, distribute and market the system in China, Macau, Hong Kong and Taiwan
-
PeriCoach Health Economics Whitepaper24 November 2020
Using PeriCoach in conservative urinary incontinence treatment plans is on-par with traditional supervised pelvic floor physical therapy at a significantly lower cost to patients and payers.
-
Publication of Randomised Controlled Clinical Trial Findings Demonstrating PeriCoach® Parity to Physical Therapy Intervention for Stress Urinary Incontinence20 November 2020
PeriCoach showed non-inferiority for treating Stress Urinary Incontinence to traditional supervised pelvic floor physical therapy.
-
CE Mark for Pelvic Organ Prolapse18 April 2019
The PeriCoach system is now CE-Marked to assist in the conservative treatment of Pelvic Organ Prolapse in addition to urinary incontinence.
-
PeriCoach Expands Clinical Indication to Include Pelvic Organ Prolapse2 May 2018
Analytica is pleased to announce that it has received Australian TGA clearance for the expanded clinical indication for the PeriCoach System to assist in the conservative treatment of Pelvic Organ Prolapse.
-
Appointment of Navigant Capital Advisors6 November 2017
Analytica is pleased to announce that New York based Investment Bank, Navigant Capital Advisors LLC has been retained by Analytica to run the process for the sale of PeriCoach, AutoStart Burette and the possible sale of the company.
-
Corporate Plan Progress Update27 September 2017
Analytica is pleased to announce the next step in development of the PeriCoach® and AutoStart® Burette with the appointment of a US corporate advisory firm.
-
PeriCoach granted patent protection in Australia11 May 2017
Analytica has been granted patent protection in the Australia for the device’s unique pelvic floor force sensing technology.
-
PeriCoach Releases 8-week Challenge Exercise Programme4 May 2017
Analytica has released a scientifically-developed, structured exercise programme for the PeriCoach system App to drive motivation and exercise compliance.
-
PeriCoach Version 3 Device Released1 May 2017
Analytica has today released the first production units of the next generation Version 3 PeriCoach device.
-
PeriCoach granted patent protection in Japan22 February 2017
Analytica has been granted patent protection in the Japan for the device’s unique pelvic floor force sensing technology.
-
PeriCoach Clinical Trial Reveals Marked Improvement in Quality of Life, Sexual Function and Continence.21 February 2017
-
PeriCoach granted patent protection in China3 August 2016
Analytica has been granted patent protection in the People’s Republic of China for the device’s unique pelvic floor force sensing technology.
-
AutoStart Burette granted US Patent15 July 2016
Analytica is pleased to announce that the AutoStart burette system has been granted patent protection by the US Patent and Trademarks Office. US Patent 9352080 has a priority date of 13 October 2005 and will expire on 17 Jan 2031.
-
Analytica receives FDA Over-the-Counter clearance for PeriCoach12 July 2016
Analytica Ltd is pleased to announce that the US Food and Drug Administration has granted the company over-the-counter clearance for the PeriCoach system, previously available in the US by prescription only.
-
Appointment of additional PeriCoach distributors for UK and Ireland29 January 2016
Analytica announces the appointment of two new distribution partners for UK and Ireland.
-
Analytica partners with leading commercialisation company SalesForce4Hire28 September 2015
Analytica is pleased to announce its entry into a services agreement with SalesForce4Hire, LLC, to grow sales of PeriCoach in the US market.
-
Analytica and Current Technology Sign US PeriCoach Distribution Agreement1 July 2015
Analytica has entered into a non-exclusive distribution agreement with Current Technology, Inc in the United States of America.
-
PeriCoach® US Commercial Launch Publicity Campaign25 June 2015
Analytica is pleased to update shareholders on this week’s commercial launch in the United States.
-
PeriCoach Clinical Trial Recruitment Commences16 April 2015
Analytica commences patient recruitment for a Clinical Trial for PeriCoach.
-
PeriCoach recieves 510(k) Clearance in USA19 March 2015
Analytica is pleased to announce that the PeriCoach has recieved 510(k) clearance in the USA. This clearance allows the PeriCoach system to be marketed and sold in the United States and its territories.
-
PeriCoach App now available on iTunes12 January 2015
Analytica is pleased to announce that the PeriCoach app for iOS has been approved by Apple and is now available for download by iPhone users from iTunes.
-
PeriCoach Product Released24 November 2014
Analytica Limited announces the consumer introduction of PeriCoach.
-
Product Release Update13 November 2014
Analytica Limited advises that the updated, dual-operating system product version has its first batch in the final stages of production and is awaiting final iOS app approvals from Apple Inc.
-
Prominent US Healthcare PR firm to drive PeriCoach global campaign7 November 2014
Analytica has appointed US specialist healthcare marketing communication agency jacobstahl Inc. to promote the launch of the PeriCoach System.
-
Analytica Prepares for PeriCoach Clinical Trial29 October 2014
Analytica is pleased to announce that it has completed the design of the Clinical Trial for the PeriCoach system. This multi-centre, randomised, controlled study intends to evaluate the efficacy of the PeriCoach system in females with stress urinary incontinence compared to unassisted pelvic floor exercise as well as the degree of user satisfaction in terms of outcome, ease of use, and improvement in sexual function.
-
MOU signed with Sportsmed Global13 October 2014
Analytica and SportsMed Global announce a non-binding Memorandum of Understanding to pursue detailed planning for the integration of the PeriCoach pelvic floor exercise system and the SportsMed system.
-
PeriCoach CE Mark Granted9 October 2014
Analytica is pleased to announce that the PeriCoach system received CE-Mark clearance overnight. This major milestone allows Analytica to legally market the PeriCoach system in Europe.
-
Analytica Announces Clinical Advisory Boards19 August 2014
Analytica is pleased to announce the composition of its Clinical Advisory Boards in Australia and the United States.
-
PeriCoach Production Commences29 May 2014
Analytica has commenced production of the PeriCoach sensor devices on schedule with first domestic sales expected in the next few weeks.
-
PeriCoach App Released in Preparation for First Sales27 May 2014
Analytica is pleased to announce that the PeriCoach app is now available for download for Android devices on the Google Play Store in preparation for imminent production and first sales.
-
Reimbursement of Urinary Incontinence Health Costs In USA and Australia. Outstanding Value.7 May 2014
An exciting and critical milestone just reached is the completion of an independent reimbursement report commissioned by Analytica for the US market.
-
PeriCoach System registered on the Australian Register of Therapeutic Goods (ARTG)13 November 2013
Analytica (ASX:ALT) takes great pleasure in announcing that it has successfully registered the PeriCoach® System with the Australian Therapeutic Goods Administration.
-
First PeriCoach Production22 October 2013
Analytica is proud to announce that the first production PeriCoach units came off the assembly line at our Sydney manufacturer yesterday. These units are the first in a limited production run to provide units for validation testing, marketing purposes, and field testing by volunteer women. This limited production build is expected to last several weeks and will also be used to develop manufacturing processes and techniques for future high volume manufacturing runs.
-
Formation of PeriCoach Clinical Advisory Board9 October 2013
Analytica is proud to announce the formation of a Clinical Advisory Board for the PeriCoach® system.
-
Chinese Patent granted for the AutoStart Infusion System14 August 2013
Analytica is pleased to announce a further opportunity for overseas sales by securing a patent covering the company's core AutoStart system intellectual property in the enormous market of the People’s Republic of China.
-
Chinese Patent Granted for AutoFlush Feature.24 July 2013
Analytica is pleased to announce that a Chinese patent titled "Flushable Injection Port" patent number ZL20098012636.9 has been granted to Analytica.
-
AutoStart System Mandarin Videos Released8 July 2013
Analytica has released Mandarin translations of the AutoStart Infusion System promotional and training videos to assist our Taiwanese Distributors.
-
Taiwan Distribution Agreement Signed7 June 2013
Analytica is pleased to announce the signing of a distribution agreement for the AutoStart® Infusion System with a major medical products distributor in Taiwan – Taiwan Allied Dragon Inc.
-
Letter of Intent signed with Taiwanese Distributor20 May 2013
Analytica is pleased to announce that it has secured a letter of intent from a major medical products distributor in Taiwan - Taiwan Allied Dragon Inc.
-
South-East Asia Marketing Initiative21 February 2013
Analytica is pleased to announce the signing of a corporate advisory agreement with South-South Capital Partners to take our AutoStart Burette technology into Indonesia, Malaysia, The Philippines, Singapore, Taiwan and Thailand.
-
Brazilian Burette Distributor Letter of Intent Signed18 December 2012
Analytica is pleased to announce that it has secured a letter of intent from a major medical products distributor in Brazil.
-
Analytica Announces New AutoStart Burette Production for US Market18 July 2012
Analytica (ASX:ALT) is pleased to announce a successful pilot production run of the Version 2 AutoStart Burette in China last week. The production was performed by our OEM manufacturing partner near Shenzhen, and is intended for the US market.
-
Commencement of Sales of Tuta Burettes with MediFlush Feature.3 July 2012
Analytica Limited (ASX:ALT) and Medical Australia Limited (ASX:MLA) are pleased to announce that sales of Tuta-branded burettes equipped with Analytica's patented flush system have commenced in the Australian market.
-
Option to Acquire Patent for Pelvic Floor Exercise System (CORRECTION)1 November 2011
Analytica wishes to correct the announcement released earlier today regarding the patent for the pelvic floor exercise system. The reference to the exclusive option to receive the assignment of the Australian Patent for the pelvic floor exercise system is incorrect, and should instead be a reference to the assignment of intellectual property relating to the pelvic floor exercise system.
-
Option to Acquire Patent for Pelvic Floor Exercise System1 November 2011
Analytica has been granted an exclusive option to receive the assignment of the Australian patent for the pelvic floor exercise system. The option will expire on 25 October 2014.
-
Supply Agreement Secured for AutoStart Burette with Concord Repatriation and General Hospital6 July 2011
Analytica Limited and Medical Australia Limited are pleased to announce that a major clinical trial using Analytica's AutoStart Burette has been successfully completed in Sydney, Australia with Concord Repatriation and General Hospital.
-
Supply Agreement Secured for AutoStart Burette with New South Wales Ambulance Service12 May 2011
Analytica Limited and Medical Australia Limited are pleased to announce that the first order has been completed under the distribution agreement signed in April 2010. NSW Ambulance Service has placed an ongoing order for AutoStart® Burettes and these devices will be carried by ambulances across the state.